Takeda Pharmaceutical (TAK) Interest Coverage Ratio (2017 - 2026)

Takeda Pharmaceutical's Interest Coverage Ratio history runs 10 years deep, the most recent figure standing at 2.81 for Q1 2026.

• On a quarterly basis, Interest Coverage Ratio fell 63.16% year-over-year to 2.81 in Q1 2026; TTM through Mar 2026 was 1.29, a 27.56% increase from a year earlier, with the FY2026 full-year figure at 0.04, down 97.43% from the prior year.
• Interest Coverage Ratio slipped to 2.81 in Q1 2026 per TAK's latest filing, from 7.66 in the prior quarter.
• Across five years, Interest Coverage Ratio topped out at 7.66 in Q4 2025 and bottomed at 2.83 in Q2 2023.
• The 5-year median for Interest Coverage Ratio is 2.22 (2025), against an average of 1.32.
• Across the five-year window, Interest Coverage Ratio plunged 452.92% in 2023 and surged 414.74% in 2025, its largest moves.
• Year by year, Interest Coverage Ratio stood at 1.84 in 2022, then grew by 2.3% to 1.8 in 2023, then surged by 182.69% to 1.49 in 2024, then jumped by 414.74% to 7.66 in 2025, then plunged by 136.66% to 2.81 in 2026.
• Per Business Quant, the three latest TAK Interest Coverage Ratio figures stand at 2.81 (Q1 2026), 7.66 (Q4 2025), and 1.35 (Q3 2025).